共 39 条
- [33] Mercury Pollution from Coal-Fired Power Plants: A Critical Analysis of the Australian Regulatory Response to Public Health RisksJOURNAL OF LAW AND MEDICINE, 2018, 26 (02) : 480 - 487Bramwell, GraceWilson, FelicityFaunce, Thomas
- [34] Compliment Response Strategies in Institutional Discourse within an Emirati Context: Focus on Power and Gender Differences in University Student-Professor Exchanges in EnglishJOURNAL OF LANGUAGE AND EDUCATION, 2023, 9 (03): : 38 - 51Deveci, Tanju
- [35] Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical RelevanceDRUG METABOLISM AND DISPOSITION, 2018, 46 (09) : 1285 - 1303Kenny, Jane R.Ramsden, DianeBuckley, David B.Dallas, ShannonFung, ConradMohutsky, MichaelEinolf, Heidi J.Chen, LiangfuDekeyser, Joshua G.Fitzgerald, MariaGoosen, Theunis C.Siu, Y. AmyWalsky, Robert L.Zhang, GeorgeTweedie, DonaldHariparsad, Niresh
- [36] Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingTRIALS, 2023, 24 (01)Law, MartinCouturier, Dominique-LaurentChoodari-Oskooei, BabakCrout, PhillipGamble, CarrolJacko, PeterPallmann, PhilipPilling, MarkRobertson, David S.Robling, MichaelSydes, Matthew R.Villar, Sofia S.Wason, JamesWheeler, GrahamWilliamson, S. FayeYap, ChristinaJaki, Thomas
- [37] Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingTrials, 24Martin LawDominique-Laurent CouturierBabak Choodari-OskooeiPhillip CroutCarrol GamblePeter JackoPhilip PallmannMark PillingDavid S. RobertsonMichael RoblingMatthew R. SydesSofía S. VillarJames WasonGraham WheelerS. Faye WilliamsonChristina YapThomas Jaki
- [38] Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharingTrials, 24 (1)Martin LawDominique-Laurent CouturierBabak Choodari-OskooeiPhillip CroutCarrol GamblePeter JackoPhilip PallmannMark PillingDavid S. RobertsonMichael RoblingMatthew R. SydesSofía S. VillarJames WasonGraham WheelerS. Faye WilliamsonChristina YapThomas Jaki
- [39] Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive ControlDRUG METABOLISM AND DISPOSITION, 2017, 45 (10) : 1049 - 1059Hariparsad, NireshRamsden, DianePalamanda, JairamDekeyser, Joshua G.Fahmi, Odette A.Kenny, Jane R.Einolf, HeidiMohutsky, MichaelPardon, MagalieSiu, Y. AmyChen, LiangfuSinz, MichaelJones, BarryWalsky, RobertDallas, ShannonBalani, Suresh K.Zhang, GeorgeBuckley, DavidTweedie, Donald